Moderna
MRNA
#1127
Rank
C$23.34 B
Marketcap
$60.67
Share price
1.68%
Change (1 day)
-37.38%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: C$23.34 Billion

As of November 2024 Moderna has a market cap of C$23.34 Billion. This makes Moderna the world's 1127th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024C$23.34 B-53.58%
2023C$50.29 B-46.29%
2022C$93.63 B-28.65%
2021C$131.23 B148.97%
2020C$52.71 B513.11%
2019C$8.59 B25.71%
2018C$6.83 B

End of Day market cap according to different sources

On Nov 12th, 2024 the market cap of Moderna was reported to be:

C$23.34 Billion
by Yahoo Finance info icon info icon
C$23.34 Billion
by CompaniesMarketCap info icon info icon
C$23.34 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$0.14 B-99.39%๐Ÿ‡บ๐Ÿ‡ธ USA
C$348.05 B 1,390.74%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.16 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
C$48.41 B 107.37%๐Ÿ‡บ๐Ÿ‡ธ USA
C$292.77 B 1,153.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$3.73 B-84.01%๐Ÿ‡บ๐Ÿ‡ธ USA
C$512.92 B 2,096.91%๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.15 B-82.20%๐Ÿ‡บ๐Ÿ‡ธ USA